Jérôme Rey
Impact in
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 36
- Acute Myeloid Leukemia Research 27
- Hematopoietic Stem Cell Transplantation 8
- Genetics 29
- Myeloproliferative Neoplasms: Diagnosis and Treatment 26
- Co-authors
- Norbert Vey (45 shared papers)Céline Chizallet (9 shared papers)Julien Mozziconacci (17 shared papers)Anne Murati (14 shared papers)Daniel Birnbaum (11 shared papers)Pascal Raybaud (5 shared papers)Aude Charbonnier (30 shared papers)Nadine Carbuccia (7 shared papers)
In The Last Decade
Jérôme Rey
125 papers receiving 3k citations
Jérôme Rey's Hit Papers
Peers
Comparison fields: 5 of 88
- Genetics 1k
- Hematology 751
- Immunology 466
- Inorganic Chemistry 260
- Pathology and Forensic Medicine 203
Countries citing papers authored by Jérôme Rey
This map shows the geographic impact of Jérôme Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Rey more than expected).
Fields of papers citing papers by Jérôme Rey
This network shows the impact of papers produced by Jérôme Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Rey. The network helps show where Jérôme Rey may publish in the future.
Co-authors
The 25 scholars most cited alongside Jérôme Rey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 278 | |
| 2 | Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study Hit paper breakdown → | 2020 | 278 |
| 3 | 2010 | 156 | |
| 4 | 2012 | 130 | |
| 5 | 2018 | 116 | |
| 6 | 2021 | 80 | |
| 7 | 2013 | 65 | |
| 8 | 2021 | 63 | |
| 9 | 2017 | 58 | |
| 10 | 2017 | 57 | |
| 11 | 2017 | 56 | |
| 12 | 2009 | 53 | |
| 13 | 2019 | 52 | |
| 14 | 2020 | 51 | |
| 15 | 2020 | 50 | |
| 16 | 2022 | 49 | |
| 17 | 2012 | 44 | |
| 18 | 2012 | 44 | |
| 19 | 2017 | 42 | |
| 20 | 2017 | 42 |
About Jérôme Rey
Jérôme Rey is a scholar working on Hematology, Genetics, Immunology, Inorganic Chemistry and Pathology and Forensic Medicine, having authored 133 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Immune Cell Function and Interaction (14 papers), Zeolite Catalysis and Synthesis (12 papers), Lymphoma Diagnosis and Treatment (10 papers), Hematopoietic Stem Cell Transplantation (8 papers), Advanced Chemical Physics Studies (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Genetics (1k citations), Hematology (751 citations), Immunology (466 citations), Inorganic Chemistry (260 citations) and Pathology and Forensic Medicine (203 citations). Jérôme Rey has collaborated with scholars based in France, Italy and Slovakia. Frequent co-authors include Norbert Vey, Céline Chizallet, Julien Mozziconacci, Anne Murati, Daniel Birnbaum, Pascal Raybaud, Aude Charbonnier, Nadine Carbuccia, Mandy Brecqueville and Tomáš Bučko. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Haematology, American Journal of Hematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.